You are here
- Home
- Drug Products
All Drug Products
- Expand All
- Collapse All
-
expand
An Open Label Prostate Cancer Study in Japanese Patients
- Study Id
- D3760C00003
- Disease
- prostate cancer
- Study Name
- D3760C00003
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Pharmacoepidemiological study in patients who use Symbicort Turbuhaler as maintenance and reliever therapy capturing over-use and under-use via the General Practice Research Database.
- Study Id
- D5890C00017
- Disease
- asthma
- Drug Name
- Symbicort
- Study Name
- D5890C00017
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Aug 12, 2011
- D5890C00017.pdf (117 KB)
-
expand
Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Postmenopausal Women With Advanced Breast Cancer
- Study Id
- D6997L00021
- Disease
- breast cancer
- Drug Name
- Faslodex
- Study Name
- D6997L00021
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A randomised single centre phase I study to investigate the safety, tolerability and pharmacokinetics of oral multiple ascending daily doses of AZD1236 tablet by a single-blind, placebo-controlled, and single dose relative bioavailability of the oral suspension and oral tablet formulations by an open cross-over in healthy Japanese men
- Study Id
- D4260C00006
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD1236
- Study Name
- D4260C00006
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Jun 4, 2009
- D4260C00006.pdf (536 KB)
-
expand
A Randomised Double-blind Phase IIa Study (With Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination With Exemestane vs. Exemestane Alone in ER+ Breast Cancer Patients With FGFR1 Polysomy or Gene Amplification Who Have Progressed Following Treatment With One Prior Endocrine Therapy (Adjuvant or First-line Metastatic)
- Study Id
- D2610C00003
- Disease
- breast cancer
- Drug Name
- AZD4547
- Study Name
- D2610C00003
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
- Study Id
- D2270C00001
- Disease
- solid tumour
- Drug Name
- AZD2014
- Study Name
- D2270C00001
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Single and Multiple Ascending Doses in Healthy Male Japanese Subjects
- Study Id
- D2340C00003
- Drug Name
- AZD5423
- Study Name
- D2340C00003
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
QUALITY OF LIFE ANALYSIS OF PROSTATE CANCER PATIENT'S TREATMENT
- Study Id
- NIS-OHU-ZOL-2007-1
- Disease
- prostate cancer
- Drug Name
- Zoladex
- Study Name
- NIS-OHU-ZOL/2007/1
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Jun 15, 2011
- NIS-OHU-ZOL-2007/1.pdf (91 KB)
-
expand
Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects
- Study Id
- D0910C00015
- Disease
- infection
- Drug Name
- AZD5099
- Study Name
- D0910C00015
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA
- Study Id
- NIS-MENA-SA-IRS-2010/01
- Drug Name
- non drug study (oncology)
- Study Name
- NIS-MENA-SA-IRS-2010/01
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
- Expand All
- Collapse All
